Incannex Healthcare (IXHL) Accumulated Depreciation (2023 - 2026)
Incannex Healthcare (IXHL) posted quarterly Accumulated Depreciation of $525000.0 for Q1 2026, up 64.06% year-on-year from $320000.0 in Q1 2025, and up 31.91% on a QoQ basis from $398000.0 in Q4 2025.
Incannex Healthcare (IXHL) Accumulated Depreciation (2023 - 2026) Analysis & Trends
Incannex Healthcare (IXHL) has reported Accumulated Depreciation for 4 consecutive years, with $525000.0 the latest figure, recorded in Q1 2026.
- Quarterly Accumulated Depreciation rose 64.06% year-over-year to $525000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $525000.0 (up 64.06% YoY) and the FY2025 annual result came in at $269000.0, up 113.49% from the prior year.
- Accumulated Depreciation rose to $525000.0 in Q1 2026 per IXHL's latest filing, from $398000.0 in the prior quarter.
- Over the last five years, Accumulated Depreciation for IXHL reached as high as $525000.0 in Q1 2026 and fell as low as $23000.0 in Q2 2023.
- A 4-year average of $275555.6 and a median of $287000.0 in 2024 frame the typical range for Accumulated Depreciation.
- Annual changes were most pronounced in 2024 — Accumulated Depreciation soared 447.83% — and 2025, when it jumped 38.68%.
- Year by year, Accumulated Depreciation stood at $23000.0 in 2023, then surged by 1147.83% to $287000.0 in 2024, then jumped by 38.68% to $398000.0 in 2025, then soared by 31.91% to $525000.0 in 2026.
- According to Business Quant data, Accumulated Depreciation over the past three periods registered $525000.0, $398000.0, and $335000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Incannex Healthcare | 3.63 Mn | 3.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 525,000.00 |
| Dec 31, 2025 | 398,000.00 |
| Sep 30, 2025 | 335,000.00 |
| Jun 30, 2025 | 269,000.00 |
| Mar 31, 2025 | 320,000.00 |
| Dec 31, 2024 | 287,000.00 |
| Sep 30, 2024 | 197,000.00 |
| Jun 30, 2024 | 126,000.00 |
| Jun 30, 2023 | 23,000.00 |